Overview

A Comparison Study of PF708 and Forteo in Healthy Subjects

Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the pharmacokinetics (blood levels) of two teriparatide products, PF708 and Forteo, in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Pfenex, Inc
Treatments:
Teriparatide